Gelteq Limited Ordinary S... (GELS)
0.93
0.11 (13.41%)
At close: Apr 14, 2025, 3:56 PM
0.88
-4.91%
After-hours: Apr 14, 2025, 07:56 PM EDT
13.41% (1D)
| Bid | 0.84 |
| Market Cap | 8.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.23 |
| PE Ratio (ttm) | -4.04 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.95 |
| Volume | 61,150 |
| Avg. Volume (20D) | 169,637 |
| Open | 0.87 |
| Previous Close | 0.82 |
| Day's Range | 0.83 - 0.99 |
| 52-Week Range | 0.77 - 5.50 |
| Beta | -4.93 |
About GELS
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia....
Sector Healthcare
IPO Date n/a
Employees 7
Stock Exchange NASDAQ
Ticker Symbol GELS
Website https://www.gelteq.com
4 months ago
+91.02%
Gelteq shares are trading higher after the company...
Unlock content with
Pro Subscription